RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemiaDavid Koschut, Dean Nižetić|Oncogene|2020Cited by 15
Mechanical Stress Induces a Transient Suppression of Cytokine Secretion in Astrocytes Assessed at the Single‐Cell Level with a High‐Throughput Microfluidic ChipXiaowei Shao, Dean Nižetić, Yu Zhang et al.|Advanced Healthcare Materials|2021Cited by 13
RAS activation via CRLF2 signaling is a widespread mechanism in Down syndrome acute lymphoblastic leukemia regardless of RAS mutationsDavid Koschut, Dean Nižetić|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 0